Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Féger J[au]:

Search results

Items: 1 to 50 of 192

1.

Cortical areas involved in behavioral expression of external pallidum dysfunctions: A PET imaging study in non-human primates.

Galineau L, Kas A, Worbe Y, Chaigneau M, Herard AS, Guillermier M, Delzescaux T, Féger J, Hantraye P, Tremblay L.

Neuroimage. 2017 Feb 1;146:1025-1037. doi: 10.1016/j.neuroimage.2016.10.039. Epub 2016 Oct 29.

PMID:
27989846
2.

From morphology to biochemical state - intravital multiphoton fluorescence lifetime imaging of inflamed human skin.

Huck V, Gorzelanny C, Thomas K, Getova V, Niemeyer V, Zens K, Unnerstall TR, Feger JS, Fallah MA, Metze D, Ständer S, Luger TA, Koenig K, Mess C, Schneider SW.

Sci Rep. 2016 Mar 23;6:22789. doi: 10.1038/srep22789.

3.

Selective dysfunction of basal ganglia subterritories: From movement to behavioral disorders.

Tremblay L, Worbe Y, Thobois S, Sgambato-Faure V, Féger J.

Mov Disord. 2015 Aug;30(9):1155-70. doi: 10.1002/mds.26199. Epub 2015 Mar 15. Review.

PMID:
25772380
4.

In search of innovative therapeutics for neuropsychiatric disorders: the case of neurodegenerative diseases.

Féger J, Hirsch EC.

Ann Pharm Fr. 2015 Jan;73(1):3-12. doi: 10.1016/j.pharma.2014.10.001. Epub 2014 Nov 4. Review.

PMID:
25577012
5.

Cortico-basal ganglia circuits involved in different motivation disorders in non-human primates.

Sgambato-Faure V, Worbe Y, Epinat J, Féger J, Tremblay L.

Brain Struct Funct. 2016 Jan;221(1):345-64. doi: 10.1007/s00429-014-0911-9. Epub 2014 Oct 11.

PMID:
25304400
6.

Towards a primate model of Gilles de la Tourette syndrome: anatomo-behavioural correlation of disorders induced by striatal dysfunction.

Worbe Y, Sgambato-Faure V, Epinat J, Chaigneau M, Tandé D, François C, Féger J, Tremblay L.

Cortex. 2013 Apr;49(4):1126-40. doi: 10.1016/j.cortex.2012.08.020. Epub 2012 Sep 7.

PMID:
23040317
7.

Effects of dopamine and serotonin antagonist injections into the striatopallidal complex of asymptomatic MPTP-treated monkeys.

Neumane S, Mounayar S, Jan C, Epinat J, Ballanger B, Costes N, Féger J, Thobois S, François C, Sgambato-Faure V, Tremblay L.

Neurobiol Dis. 2012 Oct;48(1):27-39. doi: 10.1016/j.nbd.2012.06.002. Epub 2012 Jun 21.

PMID:
22728661
8.

Discontinuous long-train stimulation in the anterior striatum in monkeys induces abnormal behavioral states.

Worbe Y, Epinat J, Féger J, Tremblay L.

Cereb Cortex. 2011 Dec;21(12):2733-41. doi: 10.1093/cercor/bhr063. Epub 2011 Apr 20.

PMID:
21508304
9.

[Basal ganglia and psychiatric disorders: an experimental validation].

Féger J, Worbe Y, Galineau L, Tremblay L.

Ann Pharm Fr. 2009 Sep;67(5):320-34. doi: 10.1016/j.pharma.2009.06.003. Epub 2009 Aug 8. Review. French.

PMID:
19695368
10.

[News on the Alzheimer's disease].

Féger J.

Ann Pharm Fr. 2009 Mar;67(2):67-8. doi: 10.1016/j.pharma.2008.12.001. Epub 2009 Jan 29. French. No abstract available.

PMID:
19298888
11.

Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum.

Worbe Y, Baup N, Grabli D, Chaigneau M, Mounayar S, McCairn K, Féger J, Tremblay L.

Cereb Cortex. 2009 Aug;19(8):1844-56. doi: 10.1093/cercor/bhn214. Epub 2008 Dec 9.

PMID:
19068490
12.

Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis.

Boulet S, Mounayar S, Poupard A, Bertrand A, Jan C, Pessiglione M, Hirsch EC, Feuerstein C, François C, Féger J, Savasta M, Tremblay L.

J Neurosci. 2008 Sep 17;28(38):9575-84. doi: 10.1523/JNEUROSCI.3465-08.2008.

13.

High-frequency stimulation of the anterior subthalamic nucleus reduces stereotyped behaviors in primates.

Baup N, Grabli D, Karachi C, Mounayar S, François C, Yelnik J, Féger J, Tremblay L.

J Neurosci. 2008 Aug 27;28(35):8785-8. doi: 10.1523/JNEUROSCI.2384-08.2008.

14.

A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery.

Mounayar S, Boulet S, Tandé D, Jan C, Pessiglione M, Hirsch EC, Féger J, Savasta M, François C, Tremblay L.

Brain. 2007 Nov;130(Pt 11):2898-914. Epub 2007 Sep 13.

PMID:
17855373
15.

Impact on adenosine stress cardiac magnetic resonance for recanalisation and follow up of chronic total coronary occlusions.

Heyne JP, Goernig M, Feger J, Kurrat C, Werner GS, Figulla HR, Kaiser WA.

Eur J Radiol. 2007 Sep;63(3):384-90. Epub 2007 Mar 7.

PMID:
17346915
16.

Parafascicular nucleus projection to the extrastriatal basal ganglia in monkeys.

Tandé D, Féger J, Hirsch EC, François C.

Neuroreport. 2006 Feb 27;17(3):277-80.

PMID:
16462597
17.

The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy.

Höglinger GU, Lannuzel A, Khondiker ME, Michel PP, Duyckaerts C, Féger J, Champy P, Prigent A, Medja F, Lombes A, Oertel WH, Ruberg M, Hirsch EC.

J Neurochem. 2005 Nov;95(4):930-9. Epub 2005 Aug 10.

18.

The cerebellum communicates with the basal ganglia.

Hoshi E, Tremblay L, Féger J, Carras PL, Strick PL.

Nat Neurosci. 2005 Nov;8(11):1491-3. Epub 2005 Oct 2.

PMID:
16205719
19.

[Pharmacology, an innovative factor in therapeutic research].

Clostre F, Uzan A, Adolphe M, Bourillet F, Boulu RG, Féger J, Tillement JP.

Ann Pharm Fr. 2005 Mar;63(2):110-3. French.

PMID:
15976675
20.

Measurement of skin vasoconstrictor response in healthy subjects.

Feger J, Braune S.

Auton Neurosci. 2005 Jun 15;120(1-2):88-96.

PMID:
15951246
21.

Thalamic neuronal activity in dopamine-depleted primates: evidence for a loss of functional segregation within basal ganglia circuits.

Pessiglione M, Guehl D, Rolland AS, François C, Hirsch EC, Féger J, Tremblay L.

J Neurosci. 2005 Feb 9;25(6):1523-31.

22.

Experimental evidence for a toxic etiology of tropical parkinsonism.

Höglinger GU, Michel PP, Champy P, Feger J, Hirsch EC, Ruberg M, Lannuzel A.

Mov Disord. 2005 Jan;20(1):118-9. No abstract available.

PMID:
15390126
23.

Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease.

Corvol JC, Muriel MP, Valjent E, Féger J, Hanoun N, Girault JA, Hirsch EC, Hervé D.

J Neurosci. 2004 Aug 4;24(31):7007-14.

24.

Behavioural disorders induced by external globus pallidus dysfunction in primates II. Anatomical study.

François C, Grabli D, McCairn K, Jan C, Karachi C, Hirsch EC, Féger J, Tremblay L.

Brain. 2004 Sep;127(Pt 9):2055-70. Epub 2004 Aug 3.

PMID:
15292054
25.

Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study.

Grabli D, McCairn K, Hirsch EC, Agid Y, Féger J, François C, Tremblay L.

Brain. 2004 Sep;127(Pt 9):2039-54. Epub 2004 Aug 3.

PMID:
15292053
26.

Disruption of self-organized actions in monkeys with progressive MPTP-induced parkinsonism: II. Effects of reward preference.

Pessiglione M, Guehl D, Jan C, François C, Hirsch EC, Féger J, Tremblay L.

Eur J Neurosci. 2004 Jan;19(2):437-46.

PMID:
14725638
27.

Disruption of self-organized actions in monkeys with progressive MPTP-induced parkinsonism. I. Effects of task complexity.

Pessiglione M, Guehl D, Hirsch EC, Féger J, Tremblay L.

Eur J Neurosci. 2004 Jan;19(2):426-36.

PMID:
14725637
28.

Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe.

Champy P, Höglinger GU, Féger J, Gleye C, Hocquemiller R, Laurens A, Guérineau V, Laprévote O, Medja F, Lombès A, Michel PP, Lannuzel A, Hirsch EC, Ruberg M.

J Neurochem. 2004 Jan;88(1):63-9.

29.

Animal models of Parkinson's disease in rodents induced by toxins: an update.

Hirsch EC, Höglinger G, Rousselet E, Breidert T, Parain K, Feger J, Ruberg M, Prigent A, Cohen-Salmon C, Launay JM.

J Neural Transm Suppl. 2003;(65):89-100. Review.

PMID:
12946051
30.

Tremor-related activity of neurons in the 'motor' thalamus: changes in firing rate and pattern in the MPTP vervet model of parkinsonism.

Guehl D, Pessiglione M, François C, Yelnik J, Hirsch EC, Féger J, Tremblay L.

Eur J Neurosci. 2003 Jun;17(11):2388-400.

PMID:
12814370
31.

Impairment of context-adapted movement selection in a primate model of presymptomatic Parkinson's disease.

Pessiglione M, Guehl D, Agid Y, Hirsch EC, Féger J, Tremblay L.

Brain. 2003 Jun;126(Pt 6):1392-408.

PMID:
12764060
32.

Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats.

Höglinger GU, Féger J, Prigent A, Michel PP, Parain K, Champy P, Ruberg M, Oertel WH, Hirsch EC.

J Neurochem. 2003 Feb;84(3):491-502.

33.

Nondopaminergic neurons in Parkinson's disease.

Hirsch EC, Orieux G, Muriel MP, Francois C, Feger J.

Adv Neurol. 2003;91:29-37. Review. No abstract available.

PMID:
12449099
34.
35.

Behavioral consequences of bicuculline injection in the subthalamic nucleus and the zona incerta in rat.

Périer C, Tremblay L, Féger J, Hirsch EC.

J Neurosci. 2002 Oct 1;22(19):8711-9.

36.

[Experimental models of Parkinson's disease].

Féger J, Pessigliore M, François C, Tremblay L, Hirsch E.

Ann Pharm Fr. 2002 Jan;60(1):3-21. Review. French.

PMID:
11976545
37.

Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain.

Hassani OK, Mouroux M, Bohme GA, Stutzmann JM, Féger J.

Mov Disord. 2001 Nov;16(6):1110-4.

PMID:
11748743
38.

Metabolic effects of nigrostriatal denervation in basal ganglia.

Hirsch EC, Périer C, Orieux G, François C, Féger J, Yelnik J, Vila M, Levy R, Tolosa ES, Marin C, Trinidad Herrero M, Obeso JA, Agid Y.

Trends Neurosci. 2000 Oct;23(10 Suppl):S78-85. Review.

PMID:
11052224
39.

Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion.

Périer C, Agid Y, Hirsch EC, Féger J.

Neuroreport. 2000 Sep 28;11(14):3275-8.

PMID:
11043563
40.

Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease.

Orieux G, Francois C, Féger J, Yelnik J, Vila M, Ruberg M, Agid Y, Hirsch EC.

Neuroscience. 2000;97(1):79-88.

PMID:
10771341
41.

[Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)].

Damier P, Tremblay L, Féger J, Hirsch EC.

Rev Neurol (Paris). 2000 Mar;156(3):224-35. Review. French.

PMID:
10740093
42.

Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats.

Périer C, Vila M, Féger J, Agid Y, Hirsch EC.

Exp Neurol. 2000 Mar;162(1):215-24.

PMID:
10716902
43.

Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements.

Vila M, Périer C, Féger J, Yelnik J, Faucheux B, Ruberg M, Raisman-Vozari R, Agid Y, Hirsch EC.

Eur J Neurosci. 2000 Jan;12(1):337-44.

PMID:
10651888
45.
46.
47.
48.

Updating the functional model of the basal ganglia.

Féger J.

Trends Neurosci. 1997 Apr;20(4):152-3. No abstract available.

PMID:
9106354
49.

Evaluation of hepatic antioxidant systems after intravenous administration of polymeric nanoparticles.

Fernández-Urrusuno R, Fattal E, Féger J, Couvreur P, Thérond P.

Biomaterials. 1997 Mar;18(6):511-7.

PMID:
9111956
50.

Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat.

Hassani OK, François C, Yelnik J, Féger J.

Brain Res. 1997 Feb 21;749(1):88-94.

PMID:
9070631

Supplemental Content

Support Center